Asr Vermogensbeheer N.V. Moderna, Inc. Transaction History
Asr Vermogensbeheer N.V.
- $7.71 Trillion
- Q2 2025
A detailed history of Asr Vermogensbeheer N.V. transactions in Moderna, Inc. stock. As of the latest transaction made, Asr Vermogensbeheer N.V. holds 19,327 shares of MRNA stock, worth $504,821. This represents 0.01% of its overall portfolio holdings.
Number of Shares
19,327
Previous 21,647
10.72%
Holding current value
$504,821
Previous $614 Million
13.11%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding MRNA
# of Institutions
854Shares Held
253MCall Options Held
23.9MPut Options Held
30.2M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.06 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$668 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$577 Million0.48% of portfolio
-
State Street Corp Boston, MA17.8MShares$464 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$232 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.2B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...